626-72-2

626-72-2 structure
626-72-2 structure
  • Name: L-Homocystine
  • Chemical Name: L-Homocystine
  • CAS Number: 626-72-2
  • Molecular Formula: C8H16N2O4S2
  • Molecular Weight: 268.354
  • Catalog: Biochemical Common amino acids and protein drugs
  • Create Date: 2018-08-30 15:05:20
  • Modify Date: 2024-01-09 18:50:05
  • L-Homocystine is the oxidized member of the L-homocysteine. Homocysteine is a pro-thrombotic factor, vasodilation impairing agent, pro-inflammatory factor and endoplasmatic reticulum-stress inducer used to study cardiovascular disease mechanisms.

Name L-Homocystine
Synonyms L-Homocystine
Dl-Homocycine
(2S,2'S)-4,4'-Dithiobis(2-aminobutanoic acid)
dl-homocystine crystalline
HOMOCYSTINE,DL
Butanoic acid, 4,4'-dithiobis[2-amino-, (2S,2'S)-
QVYZ2SS2YZVQ &&L-L Form
(2S,2'S)-4,4'-Disulfanediylbis(2-aminobutanoic acid)
EINECS 210-962-5
H-DL-Hcys-OH)2
homocystine
(2S,2'S)-4,4'-Dithiobis(2-aminobutyric acid)
MFCD00020391
DL-Homocystine
H-HoCys-OH
(H-HoCys-OH)2
Description L-Homocystine is the oxidized member of the L-homocysteine. Homocysteine is a pro-thrombotic factor, vasodilation impairing agent, pro-inflammatory factor and endoplasmatic reticulum-stress inducer used to study cardiovascular disease mechanisms.
Related Catalog
Target

Human Endogenous Metabolite

In Vivo A single or multiple doses of L-Homocystine administered to mice during organogenesis can aggravate the developmental disturbances caused by a single dose of VPA administered on GD 8. Whereas, VPA lowers significantly plasma FA and vitamin B12 concentrations, it has no direct impact on the homocysteine concentrations. Therefore, it is proposed that high levels of homocysteine disturb the FA, vitamin B12, and possibly methionine metabolism thus providing a favorable situation for VPA to interfere with the development of susceptible embryos[1].
Animal Admin Mice[1] Groups of mice are first injected on GD 8 with a single dose of 75 mg/kg of L-Homocystine or an equal volume of saline. One half of the L-Homocystine-treated animals then receive a single dose of 600 mg/kg of VPA ((H-HoCys-OH)2+VPA group), while the other half are injected with a proportionate volume of saline (L-Homocystine+saline group). In the other experiment, mice are treated with a daily dose of 75 mg/kg of L-Homocystine or a proportionate volume of saline starting from GD 5 and continue through GD 10. One half of the L-Homocystine-treated animals also have a single exposure to 600 mg/kg of VPA (L-Homocystine+VPA group) or a proportionate volume of saline (L-Homocystine+saline group) on GD 8. The total volume of fluid injected corresponded to the body weight and does not exceed 0.45 mL[1].
References

[1]. Padmanabhan R, et al. Effect of maternal exposure to homocystine on sodium valproate-induced neural tube defects in the mouse embryos. Eur J Nutr. 2006 Sep;45(6):311-9

Density 1.4±0.1 g/cm3
Boiling Point 507.6±50.0 °C at 760 mmHg
Melting Point 281-284ºC (dec.)
Molecular Formula C8H16N2O4S2
Molecular Weight 268.354
Flash Point 260.8±30.1 °C
Exact Mass 268.055145
PSA 177.24000
LogP 1.03
Vapour Pressure 0.0±2.8 mmHg at 25°C
Index of Refraction 1.619
Storage condition 2~8°C
Personal Protective Equipment Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter
Safety Phrases 22-24/25
RIDADR NONH for all modes of transport
WGK Germany 3

~94%

626-72-2 structure

626-72-2

Literature: Miyazaki, Hideya; Ohta, Atsushi; Kawakatsu, Nobuyuki; Waki, Yukitaka; Gogun, Yasuhiro; et al. Bulletin of the Chemical Society of Japan, 1993 , vol. 66, # 2 p. 536 - 540

~%

626-72-2 structure

626-72-2

Literature: Biochemical Preparations, , vol. 5, p. 96 Journal of Biological Chemistry, , vol. 109, p. 97,101

~%

626-72-2 structure

626-72-2

Literature: Journal of Organic Chemistry, , vol. 57, # 1 p. 123 - 127

~%

626-72-2 structure

626-72-2

Literature: Journal of the Chemical Society, Perkin Transactions 2: Physical Organic Chemistry (1972-1999), , # 4 p. 741 - 746